Eduardo Bosch-Peligero

Department of Cardiology, Parc Taulí Hospital Universitari, Sabadell, Spain; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain

  • OrcidID

Articles by Eduardo Bosch-Peligero

Oral Anticoagulation and Prognosis of Patients with Atrial Fibrillation After Ischemic Stroke: A Real-world Data Analysis

Mario DiazNuila-Alcazar, Daniel Valcárcel-Paz, Pablo Del Castillo-Vásquez, et al

Citation: European Cardiology Review 2017;12(2):95.

DOI:

https://doi.org/10.15420/ecr.2017:23:3
Evidence-based Management of Left Main Coronary Artery Disease

Gabriel Torres-Ruiz, Nuria Mallofré-Vila, Paola Rojas-Flores, et al

Published:

Citation: European Cardiology Review 2023;18:e63.

DOI:

https://doi.org/10.15420/ecr.2023.36
Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome

G Torres-Ruiz, P Rojas-Flores, P Carrion Montaner, et al

Published:

Citation: European Cardiology Review 2023;18:e26.

DOI:

https://doi.org/10.15420/ecr.2023.18.PO9
Appropriateness of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome: Differences Between Unstable Angina and Acute Myocardial Infarction

G Torres-Ruiz, P Rojas-Flores, N Mallofré Vila, et al

Published:

Citation: European Cardiology Review 2023;18:e20.

DOI:

https://doi.org/10.15420/ecr.2023.18.PO3
LDL-C Reduction in Diabetic Patients after Percutaneous Coronary Intervention: Is There any Difference with Non-diabetic?

N Mallofré Vila, G Torres-Ruiz, C Roca-Guerrero, et al

Published:

Citation: European Cardiology Review 2023;18:e19.

DOI:

https://doi.org/10.15420/ecr.2023.18.PO2
Secondary Prevention in Patients with Non Valvular Atrial Fibrillation and Previous Stroke. Is It Possible to Have an Appropriate INR Control?

Mario DiazNuila-Alcazar, Daniel Valcárcel-Paz, Marcel Santaló-Corcoy, et al

Citation: European Cardiology Review 2017;12(2):103.

DOI:

https://doi.org/10.15420/ecr.2017:23:12